Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 1

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

Aliskiren and Fenofibrate Constrict Liver Fibrosis by means of Focusing on TGF-β1/Smad Signaling Pathway and Actuating HGF Expression

Hashim, Yasmin, Abdel Baky, Nayira, Kamal, Mona, Gad, Amany·2021·Azhar International Journal of Pharmaceutical and Medical Sciences
DOI 10.21608/aijpms.2021.54231.1028
Open this paper in CoChat — free account

Abstract

Purpose: Liver fibrosis stems from changes in fibrotic genes expression in response to tissue damage in various chronic liver diseases, with no effective therapeutic program at present. This study designed to explore the possible protective effects and the molecular targets of aliskiren (ALS) and fenofibrate (FENO) against carbon tetrachloride (CCl4)-induced liver fibrosis in rats. Methods: Wister albino rats had been injected with 0.4ml/kg 50% CCl4, three times/week for eight weeks, to establish liver fibrosis model. Concurrently, ALS (25mg/kg/day) and/or FENO (25mg/kg/day) were orally administrated for 8 weeks to rats CCl4 intoxicated. Results: Treatment with ALS and/or FENO ameliorated oxidative stress and hepatocellular damage in CCl4-intoxicated rats as indicated by the marked reduction in hepatic lipid peroxidation and serum transaminases with concomitant significant increase in hepatic superoxide dismutase (SOD) as well as glutathione (GSH) content. The magnitude of liver inflammation and fibrosis was also alleviated by both medications, as is evident from the substantial decrease in hepatic proinflammatory and profibrotic cytokines such as tumor necrosis factor a (TNF-a), interlukin-6, (IL6), C-reactive protein (CRP) and transforming growth factor-β1 (TGF-β1) with restrain in fibrous deposition alongside architecture alteration that was shown upon histopathological examination. Additionally, simultaneous administration of ALS with FENO downregulated hepatic p-Smad3 protein and increased hepatic growth factor (HGF) expression in CCl4-intoxicated rats. Conclusion: Conclusively, this study highlights the hepatoprotective effect of ALS and FENO and imply that their anti-fibrotic mechanism involves blockade of TGF-β1/Smad signaling pathway, induction of HGF expression, besides modulation of inflammation as well as oxidative stress.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.21608/aijpms.2021.54231.1028

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 20

  1. Wick G, Grundtman C, Mayerl C, Wimpissinger T-F, Feichtinger J, Zelger B, et al. The immunology of fibrosis. Annual review of immunology. 2013;31:107-35.
  2. Li W, Zhu C, Chen X, Li Y, Gao R, Wu Q. Pokeweed antiviral protein down-regulates Wnt/β-catenin signalling to attenuate liver fibrogenesis in vitro and in vivo. Digestive and Liver Disease. 2011;43(7):559-66.
  3. Hu Z, Qin F, Gao S, Zhen Y, Huang D, Dong L. Paeoniflorin exerts protective effect on radiation-induced hepatic fibrosis in rats via TGF-β1/Smads signaling pathway. American journal of translational research. 2018;10(3):1012 PMCID: PMC5883141
  4. Legendre C, Caussé E, Chaput E, Salvayre R, Pineau T, Edgar AD. Fenofibrate induces a selective increase of protein-bound homocysteine in rodents: a PPARα-mediated effect. Biochemical and biophysical research communications. 2002;295(5):1052-6.
  5. Gilgenkrantz H, de l'Hortet AC. Understanding liver regeneration: from mechanisms to regenerative medicine. The American journal of pathology. 2018;188(6):1316-27.
  6. El-Kholi E, El-beltagi HM, Abdo VB. Evaluation of the possible antifibrotic effect of aliskiren, valsartan, chloroquine, zafirlukast and colchicine on liver fibrosis induced by carbon tetrachloride in rats. Br J Med Health Res. 2015;2(7):41-54..
  7. Sirag H, Ibrahim H, Amer A, Salam T, Samaka R, El-Mowafy Y. Ameliorative effect of caffeic acid phenethyl ester and candsartain cilexetil on CCL4 induced hepatotoxicity in male rats. Annals of Biological Research. 2011;2(4):503-15.
  8. Landmesser U, Spiekermann S, Preuss C, Sorrentino S, Fischer D, Manes C, et al. Angiotensin II induces endothelial xanthine oxidase activation: role for endothelial dysfunction in patients with coronary disease. Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27(4):943-8.
  9. Toyama T, Nakamura H, Harano Y, Yamauchi N, Morita A, Kirishima T, et al. PPARα ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats. Biochemical and biophysical research communications. 2004;324(2):697-704.
  10. Toriumi K, Horikoshi Y, Osamura RY, Yamamoto Y, Nakamura N, Takekoshi S. Carbon tetrachloride-induced hepatic injury through formation of oxidized diacylglycerol and activation of the PKC/NF-κ B pathway. Laboratory Investigation. 2013;93(2):218-29.
  11. Buldak L, Dulawa-Buldak A, Labuzek K, Okopien B. Effects of 90-day hypolipidemic treatment on insulin resistance, adipokines and proinflammatory cytokines in patients https://aijpms.journals.ekb.eg/ with mixed hyperlipidemia and impaired fasting glucose. International journal of clinical pharmacology and therapeutics. 2012;50(11):805-13.
  12. Ye P, Li J-J, Su G, Zhang C. Effects of fenofibrate on inflammatory cytokines and blood pressure in patients with hypertriglyceridemia. Clinica chimica acta. 2005;1(356):229-32.
  13. Okopien B, Krysiak R, Kowalski J, Madej A, Belowski D, Zielinski M, et al. Monocyte release of tumor necrosis factor-α and interleukin-1β in primary type IIa and IIb dyslipidemic patients treated with statins or fibrates. Journal of cardiovascular pharmacology. 2005;46(3):377-86.
  14. Lalloyer F, Wouters K, Baron M, Caron S, Vallez E, Vanhoutte J, et al. Peroxisome proliferator-activated receptor-α gene level differently affects lipid metabolism and inflammation in apolipoprotein E2 knock-in mice. Arteriosclerosis, thrombosis, and vascular biology. 2011;31(7):1573-9.
  15. Shiri-Sverdlov R, Wouters K, van Gorp PJ, Gijbels MJ, Noel B, Buffat L, et al. Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates. Journal of hepatology. 2006;44(4):732-41.
  16. Chanda D, Lee CH, Kim YH, Noh JR, Kim DK, Park JH, et al. Fenofibrate differentially regulates plasminogen activator inhibitor-1 gene expression via adenosine monophosphate-activated protein kinase-dependent induction of orphan nuclear receptor small heterodimer partner. Hepatology. 2009;50(3):880-92.
  17. Al-Rasheed NM, Al-Rasheed NM, Al-Amin MA, Hasan IH, Al-Ajmi HN, Mohammad RA, et al. Fenofibrate attenuates diabetic nephropathy in experimental diabetic rat's model via suppression of augmented TGF-β 1/Smad3 signaling pathway. Archives of physiology and biochemistry. 2016;122(4):186-94.
  18. Chen XR, Besson VC, Palmier B, Garcia Y, Plotkine M, Marchand-Leroux C. Neurological recovery-promoting, anti-inflammatory, and anti-oxidative effects afforded by fenofibrate, a PPAR alpha agonist, in traumatic brain injury. Journal of neurotrauma. 2007;24(7):1119-31.
  19. Mungunsukh O, Day RM. Transforming growth factor-β1 selectively inhibits hepatocyte growth factor expression via a micro-RNA-199-dependent posttranscriptional mechanism. Molecular biology of the cell. 2013;24(13):2088-97.
  20. Harrison P, Bradley L, Bomford A. Mechanism of regulation of HGF/SF gene expression in fibroblasts by TGF-β1. Biochemical and biophysical research communications. 2000;271(1):203-11.

Cited by

See all 1

Metadata

Authors
Hashim, Y., Abdel Baky, N., Kamal, M., & Gad, A.
Venue
Azhar International Journal of Pharmaceutical and Medical Sciences
Publisher
Egypts Presidential Specialized Council for Education and Scientific Research
Published
2021-01-01
Volume
1
Issue
1
Pages
77-91
ISSN
2735-4601
DOI
10.21608/aijpms.2021.54231.1028
Cited by
0
References
65
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.